Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with Inflammatory Bowel Disease - An ECCO-EpiCom study

Journal of Crohn's and Colitis

Volumn 8, Issue 9, 2014, Pages 1030-1042

  Burisch, J ^a   Weimers, P ^a   Pedersen, N ^a   Cukovic Cavka, S ^b   Vucelic, B ^b   Kaimakliotis, I ^c   Duricova, D ^d   Bortlik, M ^d   Shonova O ^e   Vind, I ^f   Avnstrom S ^f   Thorsgaard, N ^g   Krabbe, S ^h   Andersen, V ^h,i,j   Dahlerup, J F ^k   Kjeldsen, J ^l   Salupere, R ^m   Olsen, J ⁿ   Nielsen, K R ⁿ   Manninen, P ^o   Collin, P ^o   Katsanos, K H ^p   Tsianos, E V ^p   Ladefoged, K ^q   Lakatos, L ^r   Ragnarsson, G ^s   Bjornsson E ^s   Bailey, Y ^t   O'Morain, C ^t   Schwartz, D ^u   Odes, S ^u   Valpiani, D ^v,x   Boni, M C ^w,x   Jonaitis, L ^y   Kupcinskas, L ^y   Turcan, S ^z   Barros, L ^aa   Magro, F ^ab,ac,ad   Lazar, D ^ae   Goldis, A ^ae   Nikulina, I ^af   Belousova, E ^af   Fernandez, A ^ag   Sanroman, L ^ah   Almer, S ^ai,aj   Zhulina, Y ^ak   Halfvarson, J ^ak,al   Arebi, N ^am   Diggory, T ^an,ao   Sebastian, S ^an,ao   Lakatos, P L ^ap   Langholz, E ^a   Munkholm, P ^a   more..

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c Private Practice   (Cyprus)

^d CHARLES UNIVERSITY   (Czech Republic)

^e Hospital Ceske Budejovice   (Czech Republic)

^f AMAGER HOSPITAL   (Denmark)

^g HERNING HOSPITAL   (Denmark)

^h VIBORG HOSPITAL   (Denmark)

ⁱ Hospital of Southern Jutland   (Denmark)

^j UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^k AARHUS UNIVERSITY HOSPITAL   (Denmark)

^l ODENSE UNIVERSITY HOSPITAL   (Denmark)

^m TARTU UNIVERSITY HOSPITAL   (Estonia)

ⁿ National Hospital of the Faroe Islands   (Faroe Islands)

^o TAMPERE UNIVERSITY HOSPITAL   (Finland)

^p UNIVERSITY OF IOANNINA   (Greece)

^q Dronning Ingrids Hospital   (Greenland)

^r Csolnoky F Province Hospital   (Hungary)

^s LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^t ADELAIDE AND MEATH HOSPITAL   (Ireland)

^u BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^v MORGAGNI PIERANTONI HOSPITAL   (Italy)

^w S MARIA NUOVA HOSPITAL   (Italy)

^x On behalf of the EpiCom Northern Italy Centre based in Crema and oCremona   (Italy)

^y LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^z STATE UNIVERSITY OF MEDICINE AND PHARMACY NICOLAE TESTEMITANU   (Moldova)

^aa Hospital de Vale de Sousa   (Portugal)

^ab HOSPITAL DE SÃO JOÃO   (Portugal)

^ac University of Porto   (Portugal)

^ad UNIVERSITY OF PORTO   (Portugal)

^ae VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^af M F VLADIMIRSKY MOSCOW REGIONAL RESEARCH CLINICAL INSTITUTE   (Russian Federation)

^ag HOSPITAL POVISA   (Spain)

^ah UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

^ai KAROLINSKA INSTITUTE   (Sweden)

^aj Regional Cancer Centre Southeast   (Sweden)

^ak ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^al ÖREBRO UNIVERSITY   (Sweden)

^am ST MARK S HOSPITAL   (United Kingdom)

^an HULL ROYAL INFIRMARY   (United Kingdom)

^ao UNIVERSITY OF HULL   (United Kingdom)

^ap SEMMELWEIS UNIVERSITY   (Hungary)

more..

Author keywords

Disease course; Epidemiology; ; Inception cohort; ; Quality of life;

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; BIOLOGICAL PRODUCT; CYCLOSPORIN; GLUCOCORTICOID; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; STEROID;

ABDOMINAL SURGERY; ADOLESCENT; ADULT; ARTICLE; BIOLOGICAL THERAPY; COHORT ANALYSIS; CORTICOSTEROID THERAPY; CROHN DISEASE; EASTERN EUROPE; FEMALE; FOLLOW UP; HUMAN; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 12; STEROID THERAPY; ULCERATIVE COLITIS; WESTERN EUROPE; AGED; CLINICAL TRIAL; DISEASE MANAGEMENT; EUROPE; HEALTH SURVEY; INFLAMMATORY BOWEL DISEASES; MIDDLE AGED; MORBIDITY; MULTICENTER STUDY; PROCEDURES; PROGNOSIS; PSYCHOLOGY; TRENDS; VERY ELDERLY; YOUNG ADULT; CLINICAL ASSESSMENT; DRUG MEGADOSE; EUROPEAN; SCORING SYSTEM; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DIGESTIVE SYSTEM SURGICAL PROCEDURES; DISEASE MANAGEMENT; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; MORBIDITY; POPULATION SURVEILLANCE; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; YOUNG ADULT;

EID: 84906791641     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2014.01.028     Document Type: Article

References (43)

1. Bernklev T., Jahnsen J., Lygren I., Henriksen M., Vatn M., Moum B. Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: psychometric assessments and a comparison with general population norms. Inflamm Bowel Dis 2005, 11:909-918.
2. Casellas F., Arenas J.I., Baudet J.S., Fábregas S., García N., Gelabert J., et al. Impairment of health-related quality of life in patients with inflammatory bowel disease: a Spanish multicenter study. Inflamm Bowel Dis 2005, 11:488-496.
3. Nordin K., Påhlman L., Larsson K., Sundberg-Hjelm M., Lööf L. Health-related quality of life and psychological distress in a population-based sample of Swedish patients with inflammatory bowel disease. Scand J Gastroenterol 2002, 37:450-457.
4. Munkholm P., Pedersen N. Evaluation of quality of life in inflammatory bowel disease. Crohn's Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach 2012, 333-340. Springer US, Boston, MA. D.C. Baumgart (Ed.).
5. Lix L.M., Graff L.A., Walker J.R., Clara I., Rawsthorne P., Rogala L., et al. Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease. Inflamm Bowel Dis 2008, 14:1575-1584.
6. Bernklev T., Jahnsen J., Schulz T., Sauar J., Lygren I., Henriksen M., et al. Course of disease, drug treatment and health-related quality of life in patients with inflammatory bowel disease 5years after initial diagnosis. Eur J Gastroenterol Hepatol 2005, 17:1037-1045.
7. van der Eijk I., Vlachonikolis I.G., Munkholm P., Nijman J., Bernklev T., Politi P., et al. The role of quality of care in health-related quality of life in patients with IBD. Inflamm Bowel Dis 2004, 10:392-398.
8. Elkjaer M., Moser G., Reinisch W., Durovicova D., Lukas M., Vucelic B., et al. IBD patients need in health quality of care ECCO consensus. J Crohns Colitis 2008, 2:181-188.
9. Anon European Medicines Agency. Pre-authorisation evaluation of medicines for human use Available at:, [Accessed July 4, 2008]. http://www.ema.europa.eu.
10. Anon Guidance for Industry Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics Available at:, [Accessed January 23, 2009]. http://www.fda.gov/cber/guidelines.htm.
11. Hoivik M.L., Bernklev T., Moum B. Need for standardization in population-based quality of life studies: a review of the current literature. Inflamm Bowel Dis 2010, 16:525-536.
12. Burisch J., Pedersen N., Cukovic-Cavka S., Brinar M., Kaimakliotis I., Duricova D., et al. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut 2014, [in press].
13. Burisch J., Pedersen N., Cukovic-Cavka S., Turk N., Kaimakliotis I., Duricova D., et al. Initial Disease Course and Treatment in an Inflammatory Bowel Disease Inception Cohort in Europe: The ECCO-EpiCom Cohort. Inflamm Bowel Dis 2014, 20:36-46.
14. Burisch J. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort. Dan Med J 2014, 61:B4778.
15. Munkholm P. Crohn's disease-occurrence, course and prognosis. An epidemiologic cohort-study. Dan Med Bull 1997, 44:287-302.
16. Langholz E. Ulcerative colitis. An epidemiological study based on a regional inception cohort, with special reference to disease course and prognosis. Dan Med Bull 1999, 46:400-415.
17. Vind I., Riis L., Jess T., Knudsen E., Pedersen N., Elkjaer M., et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol 2006, 101:1274-1282.
18. Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., Brant S.R., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005, 19(Suppl. A):5-36.
19. Irvine E.J., Zhou Q., Thompson A.K. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial. Am J Gastroenterol 1996, 91:1571-1578.
20. Han S.W., Gregory W., Nylander D., Tanner A., Trewby P., Barton R., et al. The SIBDQ: further validation in ulcerative colitis patients. Am J Gastroenterol 2000, 95:145-151.
21. Ware J., Kosinski M., Keller S.D. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996, 34:220-233.
22. Ware J.E., Kosinski M., Turner-Bowker D.M., Gandek B. How to score version 2 of the SF-12 Health Survey. Qual Metric Inc 2002, 1-267.
23. Ware J.E., Gandek B., Kosinski M., Aaronson N.K., Apolone G., Brazier J., et al. The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project International Quality of Life Assessment. J Clin Epidemiol 1998, 51:1167-1170.
24. Gandek B., Ware J.E., Aaronson N.K., Apolone G., Bjorner J.B., Brazier J.E., et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project International Quality of Life Assessment. J Clin Epidemiol 1998, 51:1171-1178.
25. Burisch J., Cukovic-Cavka S., Kaimakliotis I., Shonová O., Andersen V., Dahlerup J.F., et al. Construction and validation of a web-based epidemiological database for inflammatory bowel diseases in Europe An EpiCom study. J Crohns Colitis 2011, 5:342-349.
26. Hlavaty T., Persoons P., Vermeire S., Ferrante M., Pierik M., Van Assche G., et al. Evaluation of short-term responsiveness and cutoff values of inflammatory bowel disease questionnaire in Crohn's disease. Inflamm Bowel Dis 2006, 12:199-204.
27. Romberg-Camps M.J.L., Bol Y., Dagnelie P.C. Hesselink-van de Kruijs MAM, Kester ADM, Engels LGJB, et al. Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort. Inflamm Bowel Dis 2010, 16:2137-2147.
28. Hoivik M.L., Moum B., Solberg I.C., Cvancarova M., Hoie O., Vatn M.H., et al. Health-related quality of life in patients with ulcerative colitis after a 10-year disease course: results from the IBSEN study. Inflamm Bowel Dis 2012, 18:1540-1549.
29. Høivik M.L., Bernklev T., Solberg I.C., Cvancarova M., Lygren I., Jahnsen J., et al. Patients with Crohn's disease experience reduced general health and vitality in the chronic stage: ten-year results from the IBSEN study. J Crohns Colitis 2012, 6:441-453.
30. Blondel-Kucharski F., Chircop C., Marquis P., Cortot A., Baron F., Gendre J.P., et al. Health-related quality of life in Crohn's disease: a prospective longitudinal study in 231 patients. Am J Gastroenterol 2001, 96:2915-2920.
31. Casellas F., López-Vivancos J., Badia X., Vilaseca J., Malagelada J.R. Impact of surgery for Crohn's disease on health-related quality of life. Am J Gastroenterol 2000, 95:177-182.
32. Irvine E.J., Yeh C.-H., Ramsey D. Stirling a L, Higgins PDR. The effect of mesalazine therapy on quality of life in patients with mildly and moderately active ulcerative colitis. Aliment Pharmacol Ther 2008, 28:1278-1286.
33. Feagan B.G., Reinisch W., Rutgeerts P., Sandborn W.J., Yan S., Eisenberg D., et al. The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients. Am J Gastroenterol 2007, 102:794-802.
34. Feagan B.G., Yan S., Bala M., Bao W., Lichtenstein G.R. The effects of infliximab maintenance therapy on health-related quality of life. Am J Gastroenterol 2003, 98:2232-2238.
35. Bernklev T., Jahnsen J., Aadland E., Sauar J., Schulz T., Lygren I., et al. Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scand J Gastroenterol 2004, 39:365-373.
36. Casellas F., Barreiro de Acosta M., Iglesias M., Robles V., Nos P., Aguas M., et al. Mucosal healing restores normal health and quality of life in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2012, 24:762-769.
37. Irvine E.J. Quality of life issues in patients with inflammatory bowel disease. Am J Gastroenterol 1997, 92:18S-24S.
38. Casellas F., Vivancos J.L., Sampedro M., Malagelada J.-R. Relevance of the phenotypic characteristics of Crohn's disease in patient perception of health-related quality of life. Am J Gastroenterol 2005, 100:2737-2742.
39. Irvine E.J., Feagan B.G., Wong C.J. Does self-administration of a quality of life index for inflammatory bowel disease change the results?. J Clin Epidemiol 1996, 49:1177-1185.
40. Burisch J., Munkholm P. Inflammatory bowel disease epidemiology. Curr Opin Gastroenterol 2013, 29:357-362.
41. Guillemin F., Bombardier C., Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993, 46:1417-1432.
42. Buck D., Jacoby A., Baker G.A., Ley H., Steen N. Cross-cultural differences in health-related quality of life of people with epilepsy: findings from a European study. Qual Life Res 1999, 8:675-685.
43. Levenstein S., Li Z., Almer S., Barbosa A., Marquis P., Moser G., et al. Cross-cultural variation in disease-related concerns among patients with inflammatory bowel disease. Am J Gastroenterol 2001, 96:1822-1830.